Andrew Walz notifies sale of 22,200 CVX shares (CVX)

Rhea-AI Filing Summary

Andrew B Walz reported proposed sales of common stock under Rule 144. The filing lists dispositions of 22,200 shares on 02/03/2026 for $3,919,050.36 and 666 shares on 02/12/2026 for $122,144.40. The form also shows restricted stock vesting entries of 692 and 771 shares on 02/10/2026.

Insights

Securities Compliance Analyst

Rule 144 notice lists two completed dispositions and recent vesting of restricted shares.

The filing shows reported sales of 22,200 common shares and 666 common shares with exact proceeds, consistent with a Rule 144 notice of proposed sale or resale. The entries dated 02/10/2026 reflect restricted stock vesting under a registered plan.

These are routine disclosures required for certain resales; cash‑flow beneficiaries are the selling holder as reported. Subsequent filings or broker confirmations would clarify execution details and any residual lockups.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1463	268949.87	2013521597	02/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted stock vesting under a registered plan	Issuer			692	02/10/2026	Services Rendered
Common	02/10/2026	Restricted stock vesting under a registered plan	Issuer			771	02/10/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW B WALZ 1400 Smith Street Houston TX 77002	Common	02/12/2026	666	122144.40
ANDREW B WALZ 1400 Smith Street Houston TX 77002	Common	02/03/2026	22200	3919050.36

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for CVX disclose about Andrew B Walz's transactions?

The filing discloses sales of 22,200 shares on 02/03/2026 for $3,919,050.36 and 666 shares on 02/12/2026 for $122,144.40. It also lists restricted stock vesting of 692 and 771 shares on 02/10/2026.

Does the Form 144 indicate who received the sale proceeds for CVX trades?

The filing attributes the reported sales to Andrew B Walz, showing the proceeds amounts for each transaction. It does not state any other recipient; proceeds as listed correspond to the seller and the reported transactions in the form.

Are there restricted shares mentioned in the CVX Form 144 and when did they vest?

Yes. The form lists restricted stock vesting under a registered plan of 692 shares and 771 shares, each with a vesting date of 02/10/2026. These vesting entries are reported alongside the sale information.

Do these Form 144 entries for CVX signal unusual insider activity?

The filing shows reported dispositions and vesting events with exact amounts and dates, which are routine disclosures under Rule 144. The form alone does not provide additional context to indicate unusual or material change beyond the reported sales and vesting.